Study of HbA1c as a biomarker of dyslipidemia in type 2 diabetes patients

Authors

  • Dr Yogeshwar Chaudhari, Dr Annu Tiwari, Dr Suruchi Richhariya, Dr Ankit Tiwari Author

DOI:

https://doi.org/10.48047/

Abstract

Background: In type 2 diabetes mellitus, lipid abnormalities that are all recognized as major risk factors for coronary artery disease and other macro vascular complications. Present study was aimed to study HbA1c as a biomarker of dyslipidemia in type 2 diabetes patients.

 

Downloads

Download data is not yet available.

Downloads

Published

2024-07-10

Issue

Vol. 15 No. 7 (2024): volume 15 issue 7 (2024)

Section

Articles